FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo

  • D Cejka
  • , Claudia Kuntner
  • , M Preusser
  • , M Fritzer-Szekeres
  • , B Fueger
  • , S Strommer
  • , J Werzowa
  • , T Fuererder
  • , Thomas Wanek
  • , M Zsebedics
  • , M Müller
  • , Oliver Langer
  • , V Wacheck

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1739-1745
Number of pages7
JournalBritish Journal of Cancer
Volume100
Issue number11
Publication statusPublished - 2009

Research Field

  • Former Research Field - Health and Bioresources

Cite this